Clinical Trials Directory

Trials / Completed

CompletedNCT02101372

Intervention Module AGES

Gene and Environment in Schizophrenia- Research Groups in Madrid

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Celso Arango · Academic / Other
Sex
All
Age
14 Years – 19 Years
Healthy volunteers
Not accepted

Summary

The AGES-CM consortium aims to study the interaction between the polymorphisms of the candidate genes related with neurodevelopment, neurotransmission, brain progressive changes, cognitive functioning and stressful life events (prospective- and retrospectively assessed) and the association of the interactions with structural and functional brain measures, neuropsychological performance, biochemical and oxidative status in both in patients and controls. The investigators study aimed to examine the effectiveness of a parallel, structured, and specific psychoeducational group intervention (PE) for adolescent patients and their families by comparing it with treatment as usual).

Detailed description

Objective: To assess the effectiveness of a structured psychoeducational group intervention for adolescents with early onset psychosis and their families. The intervention was implemented in parallel in 2 separate groups, by focusing specifically on problem solving strategies and structured psychosis-related information to manage daily life hassles associated with the disease in order to manage crises and prevent relapses. Method: The investigators performed a 9-month, randomized, rater-blind clinical trial involving adolescent patients with early onset psychosis and 1 or both of their parents. The primary outcomes were number of hospitalizations, days of hospitalization, and visits to the emergency department. The secondary outcome measures were clinical variables and family environment and well being.

Conditions

Interventions

TypeNameDescription
BEHAVIORALtreatment as usualcase management
BEHAVIORALPsychoeducation group treatmentPsychoeducation therapy problem solving focus

Timeline

Start date
2013-01-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2014-04-02
Last updated
2015-10-07

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02101372. Inclusion in this directory is not an endorsement.